US › Healthcare

LivaNova PLC (LIVN)

US · Healthcare · Medical Devices

$85.33+3.47%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$362.3M
Revenue YoY
+14.3%
Net profit
$22.3M
Profit YoY
+106.8%
EPS
$0.98
EPS estimate
$0.90
Net margin
6.2%

EPS came in at 0.98 against a street estimate of 0.90 — a beat of 8.9%.

Key statistics

Market cap
$4.40B
P/E
40.9
Forward P/E
19.0
P/B
3.64
Book value
$22.06
EPS (TTM)
$1.96
52-week high
$85.27
52-week low
$41.87
50-day MA
$78.79
200-day MA
$66.46
Beta
0.86

Analyst view

Analysts rate LivaNova PLC a buy (8 buy, 3 hold, 0 sell out of 11) with an average price target of $84.80.

Shareholding

Insiders
0.42%
Institutions
112.93%

Largest institutional holders

FundStake
BlackRock Inc13.00%
PRIMECAP Management Company7.66%
FMR Inc4.85%
AQR Capital Management LLC4.54%
Millennium Management LLC4.44%
Artisan Partners Limited Partnership3.86%
State Street Corp3.77%
Wellington Management Company LLP3.44%

Recent filings & reports

DocumentDate
Shareholder vote results · Q2 20262026-06-11
Quarterly report · Q1 20262026-05-06
Results announced · Q2 20262026-05-06
Proxy statement · Q2 20262026-04-29
Annual report FY20252026-02-25
Results announced · Q1 20262026-02-25
Board / officer change · Q1 20262026-01-14
Quarterly report · Q3 20252025-11-05

Readable in the app.

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for LivaNova PLC — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.